Literature DB >> 29615455

Implementation of Genotype-Guided Antiplatelet Therapy: Feasible but Not Without Obstacles.

Joshua P Lewis1.   

Abstract

Entities:  

Keywords:  Editorials; aspirin; clopidogrel; genotype; percutaneous coronary intervention; pharmacogenetics

Mesh：

Substances：

Year:  2018        PMID： 29615455      PMCID： PMC5886747          DOI： 10.1161/CIRCGEN.118.002118

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN： 2574-8300


× No keyword cloud information.
  12 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

2.  Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: a randomized control trial.

Authors:  Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Xiao-Mei Li; Ying-Ying Zheng; Xiang Ma; Zhen-Yan Fu; Yan Li; Zi-Xiang Yu; You Chen; Bang-Dang Chen; Fen Liu; Ying Huang; Cheng Liu; Gulinaer Baituola
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

3.  CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina.

Authors:  Ho-Sook Kim; Kiyuk Chang; Yoon-Seok Koh; Mahn-Won Park; Yun-Seok Choi; Chul-Soo Park; Minkyung Oh; Eun-Young Kim; Ji-Hong Shon; Jae-Gook Shin; Ki-Bae Seung
Journal:  Circ Cardiovasc Genet       Date:  2013-09-09

4.  Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent.

Authors:  Jesús Sánchez-Ramos; Cristina Lucía Dávila-Fajardo; Pablo Toledo Frías; Xando Díaz Villamarín; Luis Javier Martínez-González; Susana Martínez Huertas; Francisco Burillo Gómez; Juan Caballero Borrego; Alicia Bautista Pavés; Mª Carmen Marín Guzmán; José Antonio Ramirez Hernández; Concepción Correa Vilches; Jose Cabeza Barrera
Journal:  Int J Cardiol       Date:  2016-09-26       Impact factor: 4.164

5.  Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population.

Authors:  De-Liang Shen; Bo Wang; Jing Bai; Qing Han; Chuang Liu; Xiao-Hui Huang; Jin-Ying Zhang
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

6.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

7.  Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.

Authors:  Alan R Shuldiner; Jeffrey R O'Connell; Kevin P Bliden; Amish Gandhi; Kathleen Ryan; Richard B Horenstein; Coleen M Damcott; Ruth Pakyz; Udaya S Tantry; Quince Gibson; Toni I Pollin; Wendy Post; Afshin Parsa; Braxton D Mitchell; Nauder Faraday; William Herzog; Paul A Gurbel
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

8.  Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Authors:  S A Scott; K Sangkuhl; C M Stein; J-S Hulot; J L Mega; D M Roden; T E Klein; M S Sabatine; J A Johnson; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2013-05-22       Impact factor: 6.875

9.  Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Authors:  Craig R Lee; Vindhya B Sriramoju; Alexandra Cervantes; Lucius A Howell; Nicholas Varunok; Shivanshu Madan; Kasey Hamrick; Melissa J Polasek; John Andrew Lee; Megan Clarke; Jonathan D Cicci; Karen E Weck; George A Stouffer
Journal:  Circ Genom Precis Med       Date:  2018-04

10.  Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Authors:  Larisa H Cavallari; Craig R Lee; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Julio D Duarte; Deepak Voora; Stephen E Kimmel; Caitrin W McDonough; Yan Gong; Chintan V Dave; Victoria M Pratt; Tameka D Alestock; R David Anderson; Jorge Alsip; Amer K Ardati; Brigitta C Brott; Lawrence Brown; Supatat Chumnumwat; Michael J Clare-Salzler; James C Coons; Joshua C Denny; Chrisly Dillon; Amanda R Elsey; Issam S Hamadeh; Shuko Harada; William B Hillegass; Lindsay Hines; Richard B Horenstein; Lucius A Howell; Linda J B Jeng; Mark D Kelemen; Yee Ming Lee; Oyunbileg Magvanjav; May Montasser; David R Nelson; Edith A Nutescu; Devon C Nwaba; Ruth E Pakyz; Kathleen Palmer; Josh F Peterson; Toni I Pollin; Alison H Quinn; Shawn W Robinson; Jamie Schub; Todd C Skaar; D Max Smith; Vindhya B Sriramoju; Petr Starostik; Tomasz P Stys; James M Stevenson; Nicholas Varunok; Mark R Vesely; Dyson T Wake; Karen E Weck; Kristin W Weitzel; Russell A Wilke; James Willig; Richard Y Zhao; Rolf P Kreutz; George A Stouffer; Philip E Empey; Nita A Limdi; Alan R Shuldiner; Almut G Winterstein; Julie A Johnson
Journal:  JACC Cardiovasc Interv       Date:  2017-11-01       Impact factor: 11.195
View more
  1 in total

Review 1.  Does individualized guided selection of antiplatelet therapy improve outcomes after percutaneous coronary intervention? A systematic review and meta-analysis.

Authors:  Naser Yamani; Samuel Unzek; Muhammad Hasnain Mankani; Talal Almas; Adeena Musheer; Humera Qamar; Shausha Farooq; Waqas Shahnawaz; Kaneez Fatima; Vincent Figueredo; Farouk Mookadam
Journal:  Ann Med Surg (Lond)       Date:  2022-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.